Clayface (2026): Release Date, R Rating, and Who Should (and Shouldn't) See DC's First Horror Movie

Three days before Clayface opened, this article made a recommendation with no reviews, no box office and no runtime to work from: if you liked The Substance, buy a ticket, and do not expect to stream it before early December. Eleven days after release, all three of those blanks have been filled in. This is the same article, rebuilt as a test of its own claims — the proposition being "the pre-release case for Clayface held up" — checked against the primary record four times. Two of the four survive. One is comprehensively wrong.

Naomi Ackie, who plays Dr. Caitlyn Corr in Clayface, speaking on a panel at SXSW 2026

Naomi Ackie, who plays Dr. Caitlyn Corr in Clayface, at SXSW 2026 - file photo, not a still from the film. Photo: Sara Komatsu, via Wikimedia Commons, CC BY-SA 4.0

Key takeaways

  • Reviews exist now, and they split. Rotten Tomatoes has it at 77% from 213 critic reviews against a 94% audience score from 2,500+ verified ratings; Metacritic reads 59 from 45 critics ("mixed or average") against a 7.4 user score from 234 ratings.
  • The economics worked. A $24,002,731 opening in 3,458 theatres, $44.67m domestic and $83.57m worldwide through November 1 — already past The Substance's entire lifetime worldwide gross, against a reported budget of about $40m.
  • The streaming prediction was wrong, and not narrowly. It was available to buy digitally by November 3, 2026 — eleven days after release, not the 45 this article projected.
  • Runtime: 1 hour 48 minutes. Classified by Box Office Mojo and Metacritic as Horror · Sci-Fi · Thriller, rated R for strong bloody violence, gore and nudity.

Figures checked: November 3, 2026.

Test 1: "If you loved The Substance, buy a ticket" — mostly holds, for a reason we got wrong

The recommendation was made on a resemblance: prosthetic-heavy body horror about a body that stops obeying its owner. The resemblance is real, and the critical record is now broadly supportive — 77% of 213 Rotten Tomatoes critics are positive. But the sturdier finding is the gap between the two meters, and it runs the opposite way from the usual comic-book-movie pattern.

Audiences are 17 points above critics on Rotten Tomatoes (94% against 77%) and Metacritic's users sit at 7.4 against a critic Metascore of 59 — a label of "mixed or average" from critics, "generally favorable" from users. Two aggregators built on different panels and different scales agree on the direction. The honest reading is that this is a film the people who sought it out liked considerably more than the people assigned to it, which is close to the definition of a film that rewards the audience it was aimed at. That is a better basis for the original advice than the resemblance was.

One caveat on the user numbers, since they are the part of this that moves: 2,500+ verified ratings and 234 Metacritic user ratings are small samples eleven days in, and self-selected. Treat the 94% as a signal about the opening-weekend audience rather than about everyone who will eventually watch it.

Test 2: "A $40 million low-risk experiment" — holds, and the shape is the interesting part

The original framing was that a reported budget of roughly $40m made this a cheap experiment inside the DC Universe rather than a tentpole. The reported figure traces to trade reporting rather than a studio filing, so it stays labelled as reported. What is now on the record is the return, and it is worth putting next to the comparison film directly, because the two made similar money by entirely different routes:

The Substance (2024)Clayface (2026)
DistributorMUBIWarner Bros.
Budget$18,000,000about $40,000,000 (reported)
Domestic opening$3,205,212$24,002,731 (3,458 theatres)
Domestic total$17,584,795 (22.7% of worldwide)$44,666,368 (53.5%), through Nov 1
International$59,732,017 (77.3%)$38,900,000 (46.5%)
Worldwide$77,316,812 (full run)$83,566,368 (11 days)
Runtime2 hr 21 min1 hr 48 min
Rating / genresR · Drama, Horror, Sci-FiR · Horror, Sci-Fi, Thriller

The Substance opened on three million dollars and spent months earning three-quarters of its money outside the United States. Clayface took eight times that opening in one weekend and has earned slightly over half its money domestically. Same genre, same rating, opposite release strategies — which is why "if you loved The Substance" was useful advice about content and useless advice about what the experience of seeing it would be like. A 1 hour 48 minute wide-release horror picture in 3,458 theatres is a different Friday night from a 2 hour 21 minute arthouse title you had to go looking for.

The second weekend tells you where it goes from here. October 30 to November 1 brought in $11,002,116 against the $24.00m opening — a drop of 54.2%, with the Halloween Saturday softening what would otherwise have been steeper. Widest release so far is 3,478 theatres. A film at roughly twice its reported production budget in worldwide gross after eleven days has cleared the crude rule of thumb that marketing costs push break-even to around twice the budget, though that rule is a convention rather than a disclosed figure and no studio publishes the actual number.

Tip: Now that the home release has arrived far earlier than expected, a dark room does most of the work for body horror. A home theater projector or a blu-ray player will show the prosthetic work the way it was lit. (These are Amazon Associate links — we may earn a small commission on qualifying purchases.)

Test 3: "Streaming no earlier than early December" — refuted

This is the claim that failed, and it failed because a rule of thumb was applied as if it were a schedule. The original reasoning ran: studios observe something like a 45-day theatrical window, 45 days from October 23 lands in early December, therefore early December at the earliest, probably on HBO Max.

As of November 3, 2026, Metacritic's "where to watch" panel lists Clayface as available to buy from Fandango At Home. That is day 11, not day 45. The 45-day figure describes when some titles reach a subscription service; it says nothing about premium digital purchase, which studios have for years used much earlier and increasingly use within the first fortnight on titles that front-load their box office. Our error was treating one window as the only window.

What follows for a reader deciding right now: if the question is "should I go to a theatre or wait," the waiting option is already open, and the trade-off is no longer time but format and price — a single digital purchase against however many cinema tickets your household needs. If the question is "when can I watch it at no extra cost on a service I already pay for," that is the window this article mis-stated, and we have no date for it. The honest answer is that we do not know, and that the 45-day convention is not a reliable way to guess.

Test 4: Who should still skip it

The audience numbers do not change who should stay away, and this is the part of the original article we would keep unaltered. Skip it if you want PG-13 comic-book spectacle: the MPA rating is R specifically for strong bloody violence, gore and nudity, and three separate classifiers — Box Office Mojo, Metacritic and Rotten Tomatoes — file it first under horror, not under superhero. Skip it if prosthetic body horror genuinely distresses you rather than entertains you; a 94% audience score from people who chose a film about a man losing his physical identity is not evidence that it is mild. And skip it if your interest in the DC Universe is continuity: nothing in the primary record on this release suggests it functions as a chapter in a larger arc, and a 1 hour 48 minute self-contained horror picture is not structured to carry one.

The one group we would now add: anyone who was on the fence about the ticket price. The economics in Test 2 mean this film has already done what it needed to do commercially, and the digital release in Test 3 means waiting costs you nothing in access. Fence-sitters have a cheaper option than they did eleven days ago, and that was not true when this article was first written.

FAQ

Is Clayface (2026) good? What are the reviews?

Critics are mixed-to-positive and audiences are strongly positive. Rotten Tomatoes shows 77% from 213 critic reviews and 94% from 2,500+ verified audience ratings. Metacritic shows a Metascore of 59 from 45 critics, labelled "mixed or average," against a 7.4 user score from 234 ratings.

Why is Clayface rated R?

The MPA rating is R for strong bloody violence, gore and nudity. It is classified as Horror, Sci-Fi and Thriller by Box Office Mojo and Metacritic, not as a superhero film.

How long is Clayface?

1 hour 48 minutes (108 minutes), per Box Office Mojo and Rotten Tomatoes.

How much has Clayface made at the box office?

$44,666,368 domestically and $38,900,000 internationally for $83,566,368 worldwide through November 1, 2026, from a $24,002,731 opening weekend in 3,458 theatres. Its reported production budget is about $40 million.

When can I stream or buy Clayface at home?

It was already available to buy digitally as of November 3, 2026, eleven days after its October 23 theatrical release. A date for inclusion in a subscription service has not been announced, and the commonly cited 45-day window did not predict the digital purchase date.

Is Clayface like The Substance?

In content, yes — both are R-rated, prosthetic-heavy body horror about a body that stops obeying its owner. In release shape, no. The Substance opened on $3.2m and earned 77.3% of its $77.3m worldwide total outside the United States over a long run; Clayface opened on $24.0m in 3,458 theatres and has earned just over half its money domestically in eleven days.

Related reading

Correction November 3, 2026: this article's streaming projection has been retracted. It predicted a home release no earlier than early December 2026 based on a 45-day theatrical window; the film was available to buy digitally by November 3, eleven days after release (Metacritic "where to watch" listing). Review scores, box office, runtime and genre classification, all unavailable when the article was written, have been added from primary sources, and the character name has been corrected to Dr. Caitlyn Corr (Wikipedia, Clayface (film)).

Sources

  • Box Office Mojo, Clayface — domestic $44,666,368 (53.5%), international $38,900,000 (46.5%), worldwide $83,566,368; opening $24,002,731 in 3,458 theatres; widest release 3,478 theatres; MPA R; 1 hr 48 min; Horror · Sci-Fi · Thriller; Warner Bros.; release date October 23, 2026. Daily grosses through November 1, 2026 were read from the same page; the second weekend total of $11,002,116 and the 54.2% drop are our arithmetic on those daily figures.
  • Box Office Mojo, The Substance — domestic $17,584,795 (22.7%), international $59,732,017 (77.3%), worldwide $77,316,812; domestic opening $3,205,212; budget $18,000,000; MUBI; R; 2 hr 21 min; Drama · Horror · Sci-Fi.
  • Rotten Tomatoes, Clayface — 77% Tomatometer from 213 reviews; 94% Popcornmeter from 2,500+ verified ratings; R; 1h 48m.
  • Metacritic, Clayface — Metascore 59 from 45 critic reviews ("mixed or average"); user score 7.4 from 234 ratings; Horror, Sci-Fi, Thriller; directed by James Watkins, written by Mike Flanagan and Hossein Amini; the "where to watch" panel listing a digital purchase option as of November 3, 2026.
  • Box Office Mojo, domestic release schedule for October 23, 2026 — the wide-release designation and the titles opening the same day.
  • Clayface (film) - Wikipedia — the reported budget of about $40 million (traced there to trade reporting of December 13, 2024), the February 2026 move from a September 11, 2026 date, and the cast and character names including Dr. Caitlyn Corr. Secondary source, used only where no primary record was available and labelled as reported.
  • Dread Central: "Clayface Officially Rated R for Strong Bloody Violence, Gore and Nudity" — the rating descriptor as announced.

Comments

Popular posts from this blog

Should You See Avengers: Doomsday Opening Weekend? 165 Minutes, No IMAX and 15 Titles of Homework

The Cat in the Hat (2026) Review: How the Bill Hader Reboot Actually Stacks Up Against 2003

Is Ebenezer: A Christmas Carol Too Scary for Family Movie Night? What the PG-13 Rating Actually Means

The Hunger Games: Sunrise on the Reaping Opens Nov. 20 — Who Should See It, and Who Should Skip It

Other Mommy (2026): The 45-Day Streaming Countdown Is Running — Who Should Still See It in Theaters

Wild Horse Nine (2026): It's Not the History Lesson the Trailer Implies — Who Should See It, and Who Should Skip It

Forgotten Island Release Guide: Date, PG Rating, Trailer Checks, and Who It May Suit